Branched‐chain amino acid to tyrosine ratio is an essential pre‐treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinoma
2013 ◽
Vol 47
(4)
◽
pp. 359-366
◽
Keyword(s):
2010 ◽
Vol 25
(9)
◽
pp. 1550-1555
◽
2014 ◽
Vol 45
(3)
◽
pp. 1082-1090
◽
2016 ◽
Vol 83
(6)
◽
pp. 248-256
◽
2019 ◽
Vol 71
(7)
◽
pp. 1132-1141
◽
Keyword(s):
2012 ◽
Vol 18
(12)
◽
pp. 1379
◽
1989 ◽
Vol 7
(3)
◽
pp. 251-262
◽